Lytham based VetPlus, is maximising its international potential with a 35 per cent increase in exports year on year.
VetPlus, a division of the Tangerine Group, was founded in 1995 deal in Veterinary Nutraceuticals, selling its products for dogs and cats exclusively through veterinary practices in 30 countries worldwide.
Already successful in many countries including Taiwan, Norway, Portugal, Spain, New Zealand and India, South Korea is by far the biggest growth market and the opportunity to develop in other parts of the world is huge, the firm says.
Neil Pullar, international sales director said: “We have seen a dramatic rise in exports over the past five years as the market for nutraceuticals has grown.
“People love their pets and can see the benefits in investing in preventative treatment for their animals. We only use the best quality ingredients and manufacture to the very highest standards.
“All our products are manufactured in Lytham which means we keep complete control from start to finish.
“The quality of British manufacturing is extremely important to our customers and despite some countries not being economically prosperous we are still continuing to experience growth in these countries. One of our main strengths is our flexibility and ability to produce country specific packaging in very small quantities. This allows our customers, many of whom are family owned businesses like ourselves, to grow with us without making huge financial commitments.”
VetPlus was the first to develop and patent a joint supplement for dogs, Synoquin, a best-selling joint supplement recommended by UK vets.
It is also the company behind Calmex which aids relaxation in pets that experience anxiety or nervousness in stressful conditions, such as Bonfire Night.
Neil added: “By continually investing in Rand D, we are always looking for new ingredients, formulations or solutions to give us a competitive edge.”
The Tangerine Group’s wide portfolio of animal health and wellbeing products has helped it reach an annual turnover approaching £20m with a staff of 150.
The company has grown both organically and by acquisition over the past 16 years.